Skip to main content
. 2021 Oct 18;11:100249. doi: 10.1016/j.lanepe.2021.100249

Fig. 3.

Fig 3

Cumulative incidence and 95% confidence intervals for symptomatic Covid-19 infection in individuals given a homologous ChAdOx1 nCoV-19 / ChAdOx1 nCoV-19 schedule.